Data Errors in Abstract and Main Results, Figure 1, and Table 2 - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Corrections to Data in the Abstract, Main Results, Figure 1, and Table 2

  • November 1, 2026

Share

Clinical Scorecard: Corrections to Data in the Abstract, Main Results, Figure 1, and Table 2

At a Glance

CategoryDetail
ConditionParadoxical eczema in patients receiving biologics for psoriasis
Key MechanismsThe source reports corrected data for adjusted incidence rates, exposure time, exposure numbers, and event counts; it does not describe biological mechanisms.
Target PopulationPatients receiving biologics for psoriasis, as described in the corrected original investigation.
Care SettingClinical research context; the source describes corrections to a published investigation and does not specify a care setting.

Key Highlights

  • Adjusted incidence rates of paradoxical eczema are reported per 1000 person-years rather than per 100 000 person-years.
  • Exposure time was revised in the abstract, main results, and Table 2.
  • Exposure numbers were revised in Figure 1 and Table 2.
  • Table 2 includes an updated number of events.
  • The article was corrected online, with details provided in a letter of explanation.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Patients receiving biologics for psoriasis were the population in the original investigation; the correction notice provides no further patient characteristics.

          The notice identifies biologic exposure as the study context but provides no prescribing recommendations or treatment comparisons.

          Clinical Best Practices

            Related Resources & Content

              Original Source(s)

              Related Content